SCHEMBL4065612

SCHEMBL4065612

COc1c(OC)c2ccccc2[nH]c1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.72
ALDH1A1 P00352 7/20 0.72
SMN1; SMN2 Q16637 4/20 0.72
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
HSD17B10 Q99714 3/20 0.53
PARP1 P09874 2/20 0.53
LMNA P02545 2/20 0.53
CYP1A2 P05177 2/20 0.53
TNKS O95271 1/20 0.53
GPR3 P46089 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
PARP15 Q460N3 1/20 0.53
TNKS2 Q9H2K2 1/20 0.53
DAO P14920 1/20 0.49
DDO Q99489 1/20 0.49
MAPT P10636 2/20 0.48
IDE P14735 1/20 0.48
MPI P34949 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6579186 0.84 KDM4E (0.57) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4540421 0.84 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6577224 0.84 KDM4E (0.66) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3420792 0.84 KDM4E (0.66) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7809220 0.82 KDM4E (0.64) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8602933 0.81 KDM4E (0.62) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL10648743 0.81 MAPT (0.59) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL31206974 0.81 KDM4E (0.62) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29859446 0.80 KDM4E (0.66) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9730724 0.80 KDM4E (0.66) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539754-A4 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF NOVARTIS VACCINES & DIAGNOSTIC (US) 2009-02-25 EP disclosed
EP-1539754-A2 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF Chiron Corporation (US) 2005-06-15 EP disclosed
WO-2004018419-A2 BENZIMIDAZOLE QUINOLINONES AND USES THEREOF CHIRON CORPORATION (US) 2004-03-04 WO disclosed
EP-0927718-B1 Quinolinone derivative, method for preparing the same, and anti-allergic agent DAINIPPON INK & CHEMICALS (JP) 2004-02-25 EP disclosed
US-6271416-B1 O-(HYDROCARBONOXYACETAMIDO)BENZOIC ACID DERIVATIVES AS INTERMEDIATES DAINIPPON INK AND CHEMICALS, INC. (JP) 2001-08-07 US disclosed
US-6136822-A ETHER, HYDROXY QUINOLINONE COMPOUNDS DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-10-24 US disclosed
US-6114352-A Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-09-05 US disclosed
EP-0785190-B1 Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient DAINIPPON INK & CHEMICALS (JP) 2000-08-16 EP disclosed
US-5942521-A Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-08-24 US disclosed
EP-0927718-A1 Quinolinone derivative, method for preparing the same, and anti-allergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 1999-07-07 EP disclosed
EP-0785190-A2 Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient DAINIPPON INK AND CHEMICALS, INC. (JP) 1997-07-23 EP disclosed